Staten Island, NEW%20YORK3 Active Studies

Pulmonary Embolism Clinical Trials in Staten Island, NEW%20YORK

Find 3 actively recruiting pulmonary embolism clinical trials in Staten Island, NEW%20YORK. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
400
Enrolling

Recruiting Pulmonary Embolism Studies in Staten Island

About Pulmonary Embolism Clinical Trials in Staten Island

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 3 pulmonary embolism clinical trials recruiting participants in Staten Island, NEW%20YORK. These studies are seeking a combined 400 participants. Research is being sponsored by Eli Lilly and Company, Vanda Pharmaceuticals, Jeremy Veenstra-vanderweele. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Staten Island — FAQ

Are there pulmonary embolism clinical trials in Staten Island?

Yes, there are 3 pulmonary embolism clinical trials currently recruiting in Staten Island, NEW%20YORK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Staten Island?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Staten Island research site will contact you about next steps.

Are clinical trials in Staten Island free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Staten Island studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 3 active trials in Staten Island are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated March 2, 2026 from ClinicalTrials.gov